Global Antibody Drug Conjugate Sales Market Report 2018
- QYR2634891
- 110 Pages
- June 2018
- Healthcare
The global Antibody Drug Conjugate market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.
The major players covered in this report
Seattle Genetics/Takeda
Roche
ImmunoGen
Immunomedics
Pfizer
Celldex Therapeutics
Millennium Pharmaceuticals
Bayer HealthCare
Mersana Therapeutics
Heidelberg Pharma
Oxford BioTherapeutics
Takeda Pharmaceutical Company Limited
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Adcetris
Kadcyl
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospital
Pharmaceutical Company
Research Institutions
The study objectives of this report are:
To analyze and study the global Antibody Drug Conjugate sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Antibody Drug Conjugate players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Antibody Drug Conjugate are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Antibody Drug Conjugate Manufacturers
Antibody Drug Conjugate Distributors/Traders/Wholesalers
Antibody Drug Conjugate Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Antibody Drug Conjugate market, by end-use.
Detailed analysis and profiles of additional market players.
Global Antibody Drug Conjugate Sales Market Report 2018
1 Antibody Drug Conjugate Market Overview
1.1 Product Overview and Scope of Antibody Drug Conjugate
1.2 Classification of Antibody Drug Conjugate by Product Category
1.2.1 Global Antibody Drug Conjugate Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Antibody Drug Conjugate Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Adcetris
1.2.4 Kadcyl
1.2.5 Other
1.3 Global Antibody Drug Conjugate Market by Application/End Users
1.3.1 Global Antibody Drug Conjugate Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Hospital
1.3.2 Pharmaceutical Company
1.3.3 Research Institutions
1.4 Global Antibody Drug Conjugate Market by Region
1.4.1 Global Antibody Drug Conjugate Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Antibody Drug Conjugate Status and Prospect (2013-2025)
1.4.3 Europe Antibody Drug Conjugate Status and Prospect (2013-2025)
1.4.4 China Antibody Drug Conjugate Status and Prospect (2013-2025)
1.4.5 Japan Antibody Drug Conjugate Status and Prospect (2013-2025)
1.4.6 Southeast Asia Antibody Drug Conjugate Status and Prospect (2013-2025)
1.4.7 India Antibody Drug Conjugate Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Antibody Drug Conjugate (2013-2025)
1.5.1 Global Antibody Drug Conjugate Sales and Growth Rate (2013-2025)
1.5.2 Global Antibody Drug Conjugate Revenue and Growth Rate (2013-2025)
2 Global Antibody Drug Conjugate Competition by Players/Suppliers, Type and Application
2.1 Global Antibody Drug Conjugate Market Competition by Players/Suppliers
2.1.1 Global Antibody Drug Conjugate Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Antibody Drug Conjugate Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Antibody Drug Conjugate (Volume and Value) by Type
2.2.1 Global Antibody Drug Conjugate Sales and Market Share by Type (2013-2018)
2.2.2 Global Antibody Drug Conjugate Revenue and Market Share by Type (2013-2018)
2.3 Global Antibody Drug Conjugate (Volume and Value) by Region
2.3.1 Global Antibody Drug Conjugate Sales and Market Share by Region (2013-2018)
2.3.2 Global Antibody Drug Conjugate Revenue and Market Share by Region (2013-2018)
2.4 Global Antibody Drug Conjugate (Volume) by Application
3 United States Antibody Drug Conjugate (Volume, Value and Sales Price)
3.1 United States Antibody Drug Conjugate Sales and Value (2013-2018)
3.1.1 United States Antibody Drug Conjugate Sales and Growth Rate (2013-2018)
3.1.2 United States Antibody Drug Conjugate Revenue and Growth Rate (2013-2018)
3.1.3 United States Antibody Drug Conjugate Sales Price Trend (2013-2018)
3.2 United States Antibody Drug Conjugate Sales Volume and Market Share by Players (2013-2018)
3.3 United States Antibody Drug Conjugate Sales Volume and Market Share by Type (2013-2018)
3.4 United States Antibody Drug Conjugate Sales Volume and Market Share by Application (2013-2018)
4 Europe Antibody Drug Conjugate (Volume, Value and Sales Price)
4.1 Europe Antibody Drug Conjugate Sales and Value (2013-2018)
4.1.1 Europe Antibody Drug Conjugate Sales and Growth Rate (2013-2018)
4.1.2 Europe Antibody Drug Conjugate Revenue and Growth Rate (2013-2018)
4.1.3 Europe Antibody Drug Conjugate Sales Price Trend (2013-2018)
4.2 Europe Antibody Drug Conjugate Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Antibody Drug Conjugate Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Antibody Drug Conjugate Sales Volume and Market Share by Application (2013-2018)
5 China Antibody Drug Conjugate (Volume, Value and Sales Price)
5.1 China Antibody Drug Conjugate Sales and Value (2013-2018)
5.1.1 China Antibody Drug Conjugate Sales and Growth Rate (2013-2018)
5.1.2 China Antibody Drug Conjugate Revenue and Growth Rate (2013-2018)
5.1.3 China Antibody Drug Conjugate Sales Price Trend (2013-2018)
5.2 China Antibody Drug Conjugate Sales Volume and Market Share by Players (2013-2018)
5.3 China Antibody Drug Conjugate Sales Volume and Market Share by Type (2013-2018)
5.4 China Antibody Drug Conjugate Sales Volume and Market Share by Application (2013-2018)
6 Japan Antibody Drug Conjugate (Volume, Value and Sales Price)
6.1 Japan Antibody Drug Conjugate Sales and Value (2013-2018)
6.1.1 Japan Antibody Drug Conjugate Sales and Growth Rate (2013-2018)
6.1.2 Japan Antibody Drug Conjugate Revenue and Growth Rate (2013-2018)
6.1.3 Japan Antibody Drug Conjugate Sales Price Trend (2013-2018)
6.2 Japan Antibody Drug Conjugate Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Antibody Drug Conjugate Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Antibody Drug Conjugate Sales Volume and Market Share by Application (2013-2018)
7 Southeast Asia Antibody Drug Conjugate (Volume, Value and Sales Price)
7.1 Southeast Asia Antibody Drug Conjugate Sales and Value (2013-2018)
7.1.1 Southeast Asia Antibody Drug Conjugate Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Antibody Drug Conjugate Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Antibody Drug Conjugate Sales Price Trend (2013-2018)
7.2 Southeast Asia Antibody Drug Conjugate Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Antibody Drug Conjugate Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Antibody Drug Conjugate Sales Volume and Market Share by Application (2013-2018)
8 India Antibody Drug Conjugate (Volume, Value and Sales Price)
8.1 India Antibody Drug Conjugate Sales and Value (2013-2018)
8.1.1 India Antibody Drug Conjugate Sales and Growth Rate (2013-2018)
8.1.2 India Antibody Drug Conjugate Revenue and Growth Rate (2013-2018)
8.1.3 India Antibody Drug Conjugate Sales Price Trend (2013-2018)
8.2 India Antibody Drug Conjugate Sales Volume and Market Share by Players (2013-2018)
8.3 India Antibody Drug Conjugate Sales Volume and Market Share by Type (2013-2018)
8.4 India Antibody Drug Conjugate Sales Volume and Market Share by Application (2013-2018)
9 Global Antibody Drug Conjugate Players/Suppliers Profiles and Sales Data
9.1 Seattle Genetics/Takeda
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Antibody Drug Conjugate Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Seattle Genetics/Takeda Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Roche
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Antibody Drug Conjugate Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Roche Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 ImmunoGen
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Antibody Drug Conjugate Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 ImmunoGen Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Immunomedics
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Antibody Drug Conjugate Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Immunomedics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Pfizer
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Antibody Drug Conjugate Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Pfizer Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Celldex Therapeutics
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Antibody Drug Conjugate Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Celldex Therapeutics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Millennium Pharmaceuticals
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Antibody Drug Conjugate Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Millennium Pharmaceuticals Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Bayer HealthCare
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Antibody Drug Conjugate Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Bayer HealthCare Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 Mersana Therapeutics
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Antibody Drug Conjugate Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Mersana Therapeutics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 Heidelberg Pharma
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Antibody Drug Conjugate Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Heidelberg Pharma Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview
9.11 Oxford BioTherapeutics
9.12 Takeda Pharmaceutical Company Limited
10 Antibody Drug Conjugate Maufacturing Cost Analysis
10.1 Antibody Drug Conjugate Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Antibody Drug Conjugate
10.3 Manufacturing Process Analysis of Antibody Drug Conjugate
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Antibody Drug Conjugate Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Antibody Drug Conjugate Major Manufacturers in 2017
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Antibody Drug Conjugate Market Forecast (2018-2025)
14.1 Global Antibody Drug Conjugate Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Antibody Drug Conjugate Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Antibody Drug Conjugate Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Antibody Drug Conjugate Price and Trend Forecast (2018-2025)
14.2 Global Antibody Drug Conjugate Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Antibody Drug Conjugate Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Antibody Drug Conjugate Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Antibody Drug Conjugate Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Antibody Drug Conjugate Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Antibody Drug Conjugate Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Antibody Drug Conjugate Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Antibody Drug Conjugate Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Antibody Drug Conjugate Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Antibody Drug Conjugate Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Antibody Drug Conjugate Sales Forecast by Type (2018-2025)
14.3.2 Global Antibody Drug Conjugate Revenue Forecast by Type (2018-2025)
14.3.3 Global Antibody Drug Conjugate Price Forecast by Type (2018-2025)
14.4 Global Antibody Drug Conjugate Sales Volume Forecast by Application (2018-2025)
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
Figure Product Picture of Antibody Drug Conjugate
Figure Global Antibody Drug Conjugate Sales Volume Comparison (K Units) by Type (2013-2025)
Figure Global Antibody Drug Conjugate Sales Volume Market Share by Type (Product Category) in 2017
Figure Adcetris Product Picture
Figure Kadcyl Product Picture
Figure Other Product Picture
Figure Global Antibody Drug Conjugate Sales Comparison (K Units) by Application (2013-2025)
Figure Global Sales Market Share of Antibody Drug Conjugate by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Pharmaceutical Company Examples
Table Key Downstream Customer in Pharmaceutical Company
Figure Research Institutions Examples
Table Key Downstream Customer in Research Institutions
Figure Global Antibody Drug Conjugate Market Size (Million USD) by Regions (2013-2025)
Figure United States Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Antibody Drug Conjugate Sales Volume (K Units) and Growth Rate (2013-2025)
Figure Global Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Antibody Drug Conjugate Sales Volume (K Units) (2013-2018)
Table Global Antibody Drug Conjugate Sales (K Units) of Key Players/Suppliers (2013-2018)
Table Global Antibody Drug Conjugate Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Antibody Drug Conjugate Sales Share by Players/Suppliers
Figure 2017 Antibody Drug Conjugate Sales Share by Players/Suppliers
Figure Global Antibody Drug Conjugate Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Antibody Drug Conjugate Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Antibody Drug Conjugate Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Antibody Drug Conjugate Revenue Share by Players
Table 2017 Global Antibody Drug Conjugate Revenue Share by Players
Table Global Antibody Drug Conjugate Sales (K Units) and Market Share by Type (2013-2018)
Table Global Antibody Drug Conjugate Sales Share (K Units) by Type (2013-2018)
Figure Sales Market Share of Antibody Drug Conjugate by Type (2013-2018)
Figure Global Antibody Drug Conjugate Sales Growth Rate by Type (2013-2018)
Table Global Antibody Drug Conjugate Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Antibody Drug Conjugate Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Antibody Drug Conjugate by Type (2013-2018)
Figure Global Antibody Drug Conjugate Revenue Growth Rate by Type (2013-2018)
Table Global Antibody Drug Conjugate Sales Volume (K Units) and Market Share by Region (2013-2018)
Table Global Antibody Drug Conjugate Sales Share by Region (2013-2018)
Figure Sales Market Share of Antibody Drug Conjugate by Region (2013-2018)
Figure Global Antibody Drug Conjugate Sales Growth Rate by Region in 2017
Table Global Antibody Drug Conjugate Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Antibody Drug Conjugate Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Antibody Drug Conjugate by Region (2013-2018)
Figure Global Antibody Drug Conjugate Revenue Growth Rate by Region in 2017
Table Global Antibody Drug Conjugate Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Antibody Drug Conjugate Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Antibody Drug Conjugate by Region (2013-2018)
Figure Global Antibody Drug Conjugate Revenue Market Share by Region in 2017
Table Global Antibody Drug Conjugate Sales Volume (K Units) and Market Share by Application (2013-2018)
Table Global Antibody Drug Conjugate Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Antibody Drug Conjugate by Application (2013-2018)
Figure Global Antibody Drug Conjugate Sales Market Share by Application (2013-2018)
Figure United States Antibody Drug Conjugate Sales (K Units) and Growth Rate (2013-2018)
Figure United States Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Antibody Drug Conjugate Sales Price (USD/Unit) Trend (2013-2018)
Table United States Antibody Drug Conjugate Sales Volume (K Units) by Players (2013-2018)
Table United States Antibody Drug Conjugate Sales Volume Market Share by Players (2013-2018)
Figure United States Antibody Drug Conjugate Sales Volume Market Share by Players in 2017
Table United States Antibody Drug Conjugate Sales Volume (K Units) by Type (2013-2018)
Table United States Antibody Drug Conjugate Sales Volume Market Share by Type (2013-2018)
Figure United States Antibody Drug Conjugate Sales Volume Market Share by Type in 2017
Table United States Antibody Drug Conjugate Sales Volume (K Units) by Application (2013-2018)
Table United States Antibody Drug Conjugate Sales Volume Market Share by Application (2013-2018)
Figure United States Antibody Drug Conjugate Sales Volume Market Share by Application in 2017
Figure Europe Antibody Drug Conjugate Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Antibody Drug Conjugate Sales Price (USD/Unit) Trend (2013-2018)
Table Europe Antibody Drug Conjugate Sales Volume (K Units) by Players (2013-2018)
Table Europe Antibody Drug Conjugate Sales Volume Market Share by Players (2013-2018)
Figure Europe Antibody Drug Conjugate Sales Volume Market Share by Players in 2017
Table Europe Antibody Drug Conjugate Sales Volume (K Units) by Type (2013-2018)
Table Europe Antibody Drug Conjugate Sales Volume Market Share by Type (2013-2018)
Figure Europe Antibody Drug Conjugate Sales Volume Market Share by Type in 2017
Table Europe Antibody Drug Conjugate Sales Volume (K Units) by Application (2013-2018)
Table Europe Antibody Drug Conjugate Sales Volume Market Share by Application (2013-2018)
Figure Europe Antibody Drug Conjugate Sales Volume Market Share by Application in 2017
Figure China Antibody Drug Conjugate Sales (K Units) and Growth Rate (2013-2018)
Figure China Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Antibody Drug Conjugate Sales Price (USD/Unit) Trend (2013-2018)
Table China Antibody Drug Conjugate Sales Volume (K Units) by Players (2013-2018)
Table China Antibody Drug Conjugate Sales Volume Market Share by Players (2013-2018)
Figure China Antibody Drug Conjugate Sales Volume Market Share by Players in 2017
Table China Antibody Drug Conjugate Sales Volume (K Units) by Type (2013-2018)
Table China Antibody Drug Conjugate Sales Volume Market Share by Type (2013-2018)
Figure China Antibody Drug Conjugate Sales Volume Market Share by Type in 2017
Table China Antibody Drug Conjugate Sales Volume (K Units) by Application (2013-2018)
Table China Antibody Drug Conjugate Sales Volume Market Share by Application (2013-2018)
Figure China Antibody Drug Conjugate Sales Volume Market Share by Application in 2017
Figure Japan Antibody Drug Conjugate Sales (K Units) and Growth Rate (2013-2018)
Figure Japan Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Antibody Drug Conjugate Sales Price (USD/Unit) Trend (2013-2018)
Table Japan Antibody Drug Conjugate Sales Volume (K Units) by Players (2013-2018)
Table Japan Antibody Drug Conjugate Sales Volume Market Share by Players (2013-2018)
Figure Japan Antibody Drug Conjugate Sales Volume Market Share by Players in 2017
Table Japan Antibody Drug Conjugate Sales Volume (K Units) by Type (2013-2018)
Table Japan Antibody Drug Conjugate Sales Volume Market Share by Type (2013-2018)
Figure Japan Antibody Drug Conjugate Sales Volume Market Share by Type in 2017
Table Japan Antibody Drug Conjugate Sales Volume (K Units) by Application (2013-2018)
Table Japan Antibody Drug Conjugate Sales Volume Market Share by Application (2013-2018)
Figure Japan Antibody Drug Conjugate Sales Volume Market Share by Application in 2017
Figure Southeast Asia Antibody Drug Conjugate Sales (K Units) and Growth Rate (2013-2018)
Figure Southeast Asia Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Antibody Drug Conjugate Sales Price (USD/Unit) Trend (2013-2018)
Table Southeast Asia Antibody Drug Conjugate Sales Volume (K Units) by Players (2013-2018)
Table Southeast Asia Antibody Drug Conjugate Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Antibody Drug Conjugate Sales Volume Market Share by Players in 2017
Table Southeast Asia Antibody Drug Conjugate Sales Volume (K Units) by Type (2013-2018)
Table Southeast Asia Antibody Drug Conjugate Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Antibody Drug Conjugate Sales Volume Market Share by Type in 2017
Table Southeast Asia Antibody Drug Conjugate Sales Volume (K Units) by Application (2013-2018)
Table Southeast Asia Antibody Drug Conjugate Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Antibody Drug Conjugate Sales Volume Market Share by Application in 2017
Figure India Antibody Drug Conjugate Sales (K Units) and Growth Rate (2013-2018)
Figure India Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Antibody Drug Conjugate Sales Price (USD/Unit) Trend (2013-2018)
Table India Antibody Drug Conjugate Sales Volume (K Units) by Players (2013-2018)
Table India Antibody Drug Conjugate Sales Volume Market Share by Players (2013-2018)
Figure India Antibody Drug Conjugate Sales Volume Market Share by Players in 2017
Table India Antibody Drug Conjugate Sales Volume (K Units) by Type (2013-2018)
Table India Antibody Drug Conjugate Sales Volume Market Share by Type (2013-2018)
Figure India Antibody Drug Conjugate Sales Volume Market Share by Type in 2017
Table India Antibody Drug Conjugate Sales Volume (K Units) by Application (2013-2018)
Table India Antibody Drug Conjugate Sales Volume Market Share by Application (2013-2018)
Figure India Antibody Drug Conjugate Sales Volume Market Share by Application in 2017
Table Seattle Genetics/Takeda Basic Information List
Table Seattle Genetics/Takeda Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Seattle Genetics/Takeda Antibody Drug Conjugate Sales Growth Rate (2013-2018)
Figure Seattle Genetics/Takeda Antibody Drug Conjugate Sales Global Market Share (2013-2018)
Figure Seattle Genetics/Takeda Antibody Drug Conjugate Revenue Global Market Share (2013-2018)
Table Roche Basic Information List
Table Roche Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Roche Antibody Drug Conjugate Sales Growth Rate (2013-2018)
Figure Roche Antibody Drug Conjugate Sales Global Market Share (2013-2018)
Figure Roche Antibody Drug Conjugate Revenue Global Market Share (2013-2018)
Table ImmunoGen Basic Information List
Table ImmunoGen Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure ImmunoGen Antibody Drug Conjugate Sales Growth Rate (2013-2018)
Figure ImmunoGen Antibody Drug Conjugate Sales Global Market Share (2013-2018
Figure ImmunoGen Antibody Drug Conjugate Revenue Global Market Share (2013-2018)
Table Immunomedics Basic Information List
Table Immunomedics Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Immunomedics Antibody Drug Conjugate Sales Growth Rate (2013-2018)
Figure Immunomedics Antibody Drug Conjugate Sales Global Market Share (2013-2018)
Figure Immunomedics Antibody Drug Conjugate Revenue Global Market Share (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Antibody Drug Conjugate Sales Growth Rate (2013-2018)
Figure Pfizer Antibody Drug Conjugate Sales Global Market Share (2013-2018)
Figure Pfizer Antibody Drug Conjugate Revenue Global Market Share (2013-2018)
Table Celldex Therapeutics Basic Information List
Table Celldex Therapeutics Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Celldex Therapeutics Antibody Drug Conjugate Sales Growth Rate (2013-2018)
Figure Celldex Therapeutics Antibody Drug Conjugate Sales Global Market Share (2013-2018
Figure Celldex Therapeutics Antibody Drug Conjugate Revenue Global Market Share (2013-2018)
Table Millennium Pharmaceuticals Basic Information List
Table Millennium Pharmaceuticals Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Millennium Pharmaceuticals Antibody Drug Conjugate Sales Growth Rate (2013-2018)
Figure Millennium Pharmaceuticals Antibody Drug Conjugate Sales Global Market Share (2013-2018)
Figure Millennium Pharmaceuticals Antibody Drug Conjugate Revenue Global Market Share (2013-2018)
Table Bayer HealthCare Basic Information List
Table Bayer HealthCare Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer HealthCare Antibody Drug Conjugate Sales Growth Rate (2013-2018)
Figure Bayer HealthCare Antibody Drug Conjugate Sales Global Market Share (2013-2018
Figure Bayer HealthCare Antibody Drug Conjugate Revenue Global Market Share (2013-2018)
Table Mersana Therapeutics Basic Information List
Table Mersana Therapeutics Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Mersana Therapeutics Antibody Drug Conjugate Sales Growth Rate (2013-2018)
Figure Mersana Therapeutics Antibody Drug Conjugate Sales Global Market Share (2013-2018)
Figure Mersana Therapeutics Antibody Drug Conjugate Revenue Global Market Share (2013-2018)
Table Heidelberg Pharma Basic Information List
Table Heidelberg Pharma Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Heidelberg Pharma Antibody Drug Conjugate Sales Growth Rate (2013-2018)
Figure Heidelberg Pharma Antibody Drug Conjugate Sales Global Market Share (2013-2018)
Figure Heidelberg Pharma Antibody Drug Conjugate Revenue Global Market Share (2013-2018)
Table Oxford BioTherapeutics Basic Information List
Table Takeda Pharmaceutical Company Limited Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antibody Drug Conjugate
Figure Manufacturing Process Analysis of Antibody Drug Conjugate
Figure Antibody Drug Conjugate Industrial Chain Analysis
Table Raw Materials Sources of Antibody Drug Conjugate Major Players in 2017
Table Major Buyers of Antibody Drug Conjugate
Table Distributors/Traders List
Figure Global Antibody Drug Conjugate Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Antibody Drug Conjugate Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Antibody Drug Conjugate Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global Antibody Drug Conjugate Sales Volume (K Units) Forecast by Regions (2018-2025)
Figure Global Antibody Drug Conjugate Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Antibody Drug Conjugate Sales Volume Market Share Forecast by Regions in 2025
Table Global Antibody Drug Conjugate Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Antibody Drug Conjugate Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Antibody Drug Conjugate Revenue Market Share Forecast by Regions in 2025
Figure United States Antibody Drug Conjugate Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Antibody Drug Conjugate Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Antibody Drug Conjugate Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Antibody Drug Conjugate Revenue and Growth Rate Forecast (2018-2025)
Figure China Antibody Drug Conjugate Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure China Antibody Drug Conjugate Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Antibody Drug Conjugate Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Antibody Drug Conjugate Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Antibody Drug Conjugate Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Antibody Drug Conjugate Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Antibody Drug Conjugate Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure India Antibody Drug Conjugate Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Antibody Drug Conjugate Sales (K Units) Forecast by Type (2018-2025)
Figure Global Antibody Drug Conjugate Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Antibody Drug Conjugate Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Antibody Drug Conjugate Revenue Market Share Forecast by Type (2018-2025)
Table Global Antibody Drug Conjugate Price (USD/Unit) Forecast by Type (2018-2025)
Table Global Antibody Drug Conjugate Sales (K Units) Forecast by Application (2018-2025)
Figure Global Antibody Drug Conjugate Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
